SCHEMBL11334166

SCHEMBL11334166

Nc1ccc2c(c1Cl)CNCCC2

nearest known ligand 0.70

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PNMT P11086 8/20 0.70
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
PRKACA P17612 1/20 0.42
PRKACG P22612 1/20 0.42
PRKACB P22694 1/20 0.42
HTR2A P28223 5/20 0.40
HTR2C P28335 5/20 0.40
HTR2B P41595 5/20 0.40
CD44 P16070 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11742041 0.89 PNMT (0.68) PNMTADRA2AADRA2BADRA2CHTR2A
Hydrochloric Acid SCHEMBL11744098 0.88 PNMT (0.69) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL476330 0.82 PNMT (1.00) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL30249887 0.82 PNMT (1.00) PNMTADRA2AADRA2BADRA2CHTR2A
Hydrochloric Acid SCHEMBL158709 0.81 PNMT (0.96) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL11340596 0.79 PNMT (0.70) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL11335549 0.79 PNMT (0.51) PNMTADRA2AADRA2BADRA2CPRKACA
SCHEMBL11336373 0.79 PNMT (0.70) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL11322886 0.79 PNMT (0.51) PNMTADRA2AADRA2BADRA2CPRKACA
SCHEMBL11322164 0.79 PNMT (0.51) PNMTADRA2AADRA2BADRA2CPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0002624-B1 2-BENZAZEPINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1981-10-14 EP disclosed
EP-0002624-A1 2-Benzazepine compounds, processes for their preparation and pharmaceutical compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1979-06-27 EP disclosed